Why is osteosarcoma so hard to treat? Its genome is complicated. The Osteosarcoma Institute is funding a new collaboration to target this genomic complexity and find new vulnerabilities in cancer cells. Read more: osinst.org/blog/gene-researc…
Could studying osteosarcoma across species help accelerate breakthroughs? Read Vet Candy's latest article to learn how comparative oncology could help transform outcomes for osteosarcoma patients. myvetcandy.com/news/2026/6/4…
What is The Osteosarcoma Institute? We’re a team of dedicated advocates and researchers who are solely focused on the advancement of osteosarcoma research and treatments. Get to know us and watch our new video: osinst.org/about
Thank you to everyone across the Mount Washington Valley in NH who supported Camden Bailey Cancer Foundation events benefiting Camdens' Quest 2 Cure Fund at OSI and osteosarcoma research for patients and families.
conwaydailysun.com/news/loca…@conwaydailysun
Just starting your career? You can make a lasting impact with a planned gift. By naming OSI as a beneficiary on your retirement account or life insurance, your legacy can help fight osteosarcoma. Read more: osinst.org/blog/planned-givi…
In honor of Willie Tichenor’s birthday, make a donation to OSI. 100% of proceeds go directly toward osteosarcoma research and advocacy, which is “What Willie Would Want.” Donate today: osinst.org/donate
Clinical trials move new osteosarcoma treatments from research to real life. From trial phases to benefits and risks, UT MD Anderson Cancer Center’s Dr. J. Andrew Livingston shares what families should know and the questions to ask. Read more: osinst.org/blog/what-are-cli…
May is #CancerResearchMonth, and OSI is proud to recognize and support the dedicated researchers who are working to improve osteosarcoma treatments. Read the latest on osteosarcoma research here: osinst.org/blog/category/res…
May is #CancerResearchMonth, and OSI is proud to recognize and support the dedicated researchers who are working to improve osteosarcoma treatments. Read the latest on osteosarcoma research here: osinst.org/blog/category/res…
The same healing process that repairs normal tissue also enables tumors to grow. Today, researchers are working to illuminate elements of cancer metastasis to find a cure for osteosarcoma. Read on: osinst.org/blog/tumor-microe…
This year, Evan is celebrating 20 years of being cancer free after battling osteosarcoma as a teenager. Read his inspiring story and more: osinst.org/blog/a-triathlete…
Looking to make a difference? Start a Facebook fundraiser with OSI in minutes and raise money for osteosarcoma research and advocacy today. Learn more here: osinst.org/ways-to-help/#fun…
We are pleased to announce the 2026 recipients of the AACR Scientific Achievement Awards. We look forward to celebrating their impactful contributions to cancer research at the AACR Annual Meeting. brnw.ch/21x1uIG#AACR26
Congratulations to OSI-funded researcher Dr. David Lyden on receiving the @AACR Princess Takamatsu Memorial Lectureship. This recognition reflects the significance of his work in cancer metastasis and its potential to inform new approaches to treatment.
pediatrics.weill.cornell.edu…
The Osteosarcoma Institute and the FDA brought together 370 researchers, clinicians, and industry leaders to tackle barriers in osteosarcoma drug development. This collaboration is helping build smarter paths to new treatments. Read more: osinst.org/blog/2025-fda-wor…
The OSI Strategic Advisory Board met last month to refresh OSI’s Scientific Strategic Plan and build consensus around new strategic initiatives to accelerate progress in osteosarcoma. Learn more about the SAB here: osinst.org/blog/advancing-re…
Osteosarcoma is a rare disease which makes research and funding for drug development difficult. Learn about the four biggest challenges facing osteosarcoma drug development and how OSI is helping to break down these barriers: osinst.org/blog/drug-challen…
Through strategic funding, targeted research priorities, and high-impact partnerships, OSI is advancing osteosarcoma research in hopes of finding better treatments for patients and, ultimately, a cure. Learn more: osinst.org/blog/momentum-mat…
Meet OSI’s incoming Executive Director, Alli Murdoff. Alli is expanding her long-standing relationship with OSI into a new, full time Executive Director position beginning April 1. Learn more about Alli and the OSI team: osinst.org/about/#team.